- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
June 23, 2022Robins Kaplan’s Antitrust Class Action Practice Recognized as Leader In The Field For Fourth Consecutive Year
-
June 17, 2022Robins Kaplan Secures Complete Dismissal of $160 Million Copyright and Software License Dispute
-
June 13, 2022Robins Kaplan Wins Judgment Vacating Two Confessions of Judgment Totaling Nearly $20 Million
-
July 25, 2022Tee It Up for the Troops
-
September 22, 202220th Annual Golf Tournament
-
June 21, 2022How To Oppose An Extension If You Really Need To
-
June 7, 2022Damned if You Do,
Damned if You Don’t -
June 7, 2022Take-Home COVID: The New Frontier?
-
June 24, 2022Biggest US Banks Sail Through Latest Round of Fed Stress Testing
-
June 23, 2022Powell Admits Recession Possible, Sees Tricky Path to Soft Landing
-
June 22, 2022Meta Reaches Settlement With Feds Over Allegedly Discriminatory Housing Ads
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Christopher Pinahs Joins Robins Kaplan’s Intellectual Property and Technology Group
April 14, 2017
Christopher Pinahs recently joined Robins Kaplan LLP’s Intellectual Property and Technology Litigation Group, where he focuses his practice on patent and trademark litigation. Applying his background in the biological sciences, Pinahs has extensive experience representing clients in the pharmaceutical, medical device, and agricultural arts. In all arenas, Pinahs uses his technical background to help clients develop their case and implement an appropriate strategy to achieve their business goals.
Pinahs’ trial experience includes several significant cases in the health and life sciences industry, including the representation of a generic manufacturer in its challenge of several patents directed to Purdue’s multibillion-dollar OxyContin® product. More recently, Pinahs was a member of a trial team that prevailed on several patents directed to the Alzheimer’s drug, Namenda XR®.
While attending classes at the University of Minnesota Law School, Pinahs simultaneously studied to earn his master’s degree in plant biological studies. He received his J.D. in 2011, and his M.S. in 2012.
Pinahs is active in the legal community, and his involvement includes pro bono representation through the Pro Se Project. He previously served as the chair of the Intellectual Property Practice Group for the Minnesota Federal Bar Association (2015-2016), and currently serves as a member of the Grants Committee for the Minnesota Federal Bar Association.
Related Professionals
Christopher A. Pinahs
Partner
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.